title: Boehringer Ingelheim withheld safety analyses on new anticoagulant, The BMJ investigation finds.
authors: The BMJ.
authors: Zosia
authors: Z
authors: Kmietowicz
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects* / Q000097:blood; D001562:Benzimidazoles / Q000009:adverse effects* / Q000097:blood; D000069604:Dabigatran; D030881:Disclosure; D004334:Drug Administration Schedule; D004345:Drug Industry; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D033181:Information Dissemination; D061214:Patient Safety; D011725:Pyridines / Q000009:adverse effects* / Q000097:blood; D020521:Stroke / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D011725:Pyridines; D000069604:Dabigatran